Hamadeh Tarazi

1.0k total citations
37 papers, 769 citations indexed

About

Hamadeh Tarazi is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Hamadeh Tarazi has authored 37 papers receiving a total of 769 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 17 papers in Organic Chemistry and 8 papers in Computational Theory and Mathematics. Recurrent topics in Hamadeh Tarazi's work include Synthesis and biological activity (14 papers), Computational Drug Discovery Methods (8 papers) and Melanoma and MAPK Pathways (7 papers). Hamadeh Tarazi is often cited by papers focused on Synthesis and biological activity (14 papers), Computational Drug Discovery Methods (8 papers) and Melanoma and MAPK Pathways (7 papers). Hamadeh Tarazi collaborates with scholars based in United Arab Emirates, Egypt and South Korea. Hamadeh Tarazi's co-authors include Raafat El‐Awady, Taleb H. Al‐Tel, Chandraprabha Murali, Amr Amin, Chang‐Hyun Oh, Hanan S. Anbar, Vunnam Srinivasulu, Yasser Bustanji, Hatim S. AlKhatib and Mohammad Mohammad and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and The Journal of Organic Chemistry.

In The Last Decade

Hamadeh Tarazi

37 papers receiving 758 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hamadeh Tarazi United Arab Emirates 17 338 287 131 97 94 37 769
Maha M. Abdel‐Fattah Egypt 19 314 0.9× 271 0.9× 106 0.8× 125 1.3× 70 0.7× 58 902
Burcu Çalışkan Türkiye 20 252 0.7× 458 1.6× 212 1.6× 67 0.7× 76 0.8× 51 883
Rohan J. Meshram India 16 330 1.0× 392 1.4× 95 0.7× 97 1.0× 96 1.0× 48 877
Asmaa M. AboulMagd Egypt 16 264 0.8× 356 1.2× 107 0.8× 100 1.0× 90 1.0× 47 735
Haihong Huang China 18 593 1.8× 391 1.4× 105 0.8× 65 0.7× 74 0.8× 68 1.1k
Malkeet Singh Bahia India 15 343 1.0× 255 0.9× 82 0.6× 130 1.3× 99 1.1× 35 901
Thikryat Neamatallah Saudi Arabia 18 301 0.9× 200 0.7× 73 0.6× 40 0.4× 86 0.9× 41 865
Dilep Kumar Sigalapalli India 20 508 1.5× 717 2.5× 115 0.9× 119 1.2× 109 1.2× 48 1.2k
Mohamed A. Tantawy Egypt 21 422 1.2× 602 2.1× 88 0.7× 135 1.4× 124 1.3× 50 1.2k
Fisayo A. Olotu South Africa 18 439 1.3× 160 0.6× 73 0.6× 162 1.7× 106 1.1× 79 857

Countries citing papers authored by Hamadeh Tarazi

Since Specialization
Citations

This map shows the geographic impact of Hamadeh Tarazi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamadeh Tarazi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamadeh Tarazi more than expected).

Fields of papers citing papers by Hamadeh Tarazi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hamadeh Tarazi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamadeh Tarazi. The network helps show where Hamadeh Tarazi may publish in the future.

Co-authorship network of co-authors of Hamadeh Tarazi

This figure shows the co-authorship network connecting the top 25 collaborators of Hamadeh Tarazi. A scholar is included among the top collaborators of Hamadeh Tarazi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hamadeh Tarazi. Hamadeh Tarazi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tarazi, Hamadeh, Ahmed M. Almehdi, Waseem El‐Huneidi, et al.. (2024). Metabolomics and Proteomics in Prostate Cancer Research: Overview, Analytical Techniques, Data Analysis, and Recent Clinical Applications. International Journal of Molecular Sciences. 25(10). 5071–5071. 8 indexed citations
3.
Sebastian, Anusha, Wafaa S. Ramadan, Varsha Menon, et al.. (2024). Synthesis and biological evaluation of new Camptothecin-like compounds as anticancer agents. Journal of Molecular Structure. 1328. 141271–141271. 2 indexed citations
4.
Ramadan, Wafaa S., Maha Saber-Ayad, Ekram Saleh, et al.. (2023). Design, synthesis and mechanistic anticancer activity of new acetylated 5-aminosalicylate-thiazolinone hybrid derivatives. iScience. 27(1). 108659–108659. 3 indexed citations
5.
Hersi, Fatema, Anusha Sebastian, Hamadeh Tarazi, et al.. (2023). Discovery of novel papain-like protease inhibitors for potential treatment of COVID-19. European Journal of Medicinal Chemistry. 254. 115380–115380. 14 indexed citations
6.
Sebastian, Anusha, Vunnam Srinivasulu, Hamadeh Tarazi, et al.. (2022). Design, synthesis, and biological evaluation of a new series of pyrazole derivatives: Discovery of potent and selective JNK3 kinase inhibitors. Bioorganic & Medicinal Chemistry. 69. 116894–116894. 9 indexed citations
7.
Saber-Ayad, Maha, Eman Abu‐Gharbieh, Rifat Hamoudi, et al.. (2021). Current Status of Baricitinib as a Repurposed Therapy for COVID-19. Pharmaceuticals. 14(7). 680–680. 30 indexed citations
8.
El–Gamal, Mohammed I., et al.. (2021). A Review of HER4 (ErbB4) Kinase, Its Impact on Cancer, and Its Inhibitors. Molecules. 26(23). 7376–7376. 38 indexed citations
9.
Srinivasulu, Vunnam, Mohamad Hamad, Hamadeh Tarazi, et al.. (2021). Discovery of Novel Small-Molecule Inhibitors of SARS-CoV-2 Main Protease as Potential Leads for COVID-19 Treatment. Journal of Chemical Information and Modeling. 61(9). 4745–4757. 14 indexed citations
10.
Zaraei, Seyed–Omar, Mohammed I. El–Gamal, Hanan S. Anbar, et al.. (2020). Design, synthesis, biological evaluation, and modeling studies of novel conformationally-restricted analogues of sorafenib as selective kinase-inhibitory antiproliferative agents against hepatocellular carcinoma cells. European Journal of Medicinal Chemistry. 210. 113081–113081. 17 indexed citations
11.
Abdu-Allah, Hajjaj H.M., et al.. (2019). Conjugation of 4-aminosalicylate with thiazolinones afforded non-cytotoxic potent in vitro and in vivo anti-inflammatory hybrids. Bioorganic Chemistry. 94. 103378–103378. 16 indexed citations
12.
El–Gamal, Mohammed I., Hanan S. Anbar, Hamadeh Tarazi, & Chang‐Hyun Oh. (2019). Discovery of a potent p38α/MAPK14 kinase inhibitor: Synthesis, in vitro/in vivo biological evaluation, and docking studies. European Journal of Medicinal Chemistry. 183. 111684–111684. 11 indexed citations
13.
Chaudhary, Sachin, et al.. (2018). Hepatoprotective and antioxidant potential of Nyctanthes arbor-tristis L. leaves against antitubercular drugs induced hepatotoxicity. Journal of Pharmacy & Pharmacognosy Research. 6(1). 205–215. 9 indexed citations
14.
Vazhappilly, Cijo George, Ekram Saleh, Wafaa S. Ramadan, et al.. (2018). Inhibition of SHP2 by new compounds induces differential effects on RAS/RAF/ERK and PI3K/AKT pathways in different cancer cell types. Investigational New Drugs. 37(2). 252–261. 30 indexed citations
15.
Khan, Islam Ullah, et al.. (2017). An Efficient Synthesis ofbi‐Aryl Pyrimidine Heterocycles: Potential New Drug Candidates to Treat Alzheimer's Disease. Archiv der Pharmazie. 350(3-4). 22 indexed citations
16.
Ihmaid, Saleh, Hany E. A. Ahmed, Hamadeh Tarazi, et al.. (2017). Rational design, synthesis, pharmacophore modeling, and docking studies for identification of novel potent DNA-PK inhibitors. Bioorganic Chemistry. 72. 234–247. 33 indexed citations
17.
Hasan, Sanah, et al.. (2017). Enhancing Student Communication Skills Through Arabic Language Competency and Simulated Patient Assessments. American Journal of Pharmaceutical Education. 81(4). 76–76. 14 indexed citations
18.
Al‐Qawasmeh, Raed A., et al.. (2016). Design, Synthesis and Qualitative Structure Activity Relationship Evaluations of Quinoline-Based Bisarylimidazoles as Antibacterial Motifs. Medicinal Chemistry. 12(6). 563–573. 10 indexed citations
19.
Tarazi, Hamadeh, Ekram Saleh, & Raafat El‐Awady. (2016). In-silico screening for DNA-dependent protein kinase (DNA-PK) inhibitors: Combined homology modeling, docking, molecular dynamic study followed by biological investigation. Biomedicine & Pharmacotherapy. 83. 693–703. 7 indexed citations
20.
Tarazi, Hamadeh, et al.. (2016). Design, synthesis and SAR analysis of potent BACE1 inhibitors: Possible lead drug candidates for Alzheimer's disease. European Journal of Medicinal Chemistry. 125. 1213–1224. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maha M. Abdel‐Fattah Breakdown of academic impact, for papers by Burcu Çalışkan Breakdown of academic impact, for papers by Rohan J. Meshram Breakdown of academic impact, for papers by Asmaa M. AboulMagd Breakdown of academic impact, for papers by Haihong Huang Breakdown of academic impact, for papers by Malkeet Singh Bahia Breakdown of academic impact, for papers by Thikryat Neamatallah Breakdown of academic impact, for papers by Dilep Kumar Sigalapalli Breakdown of academic impact, for papers by Mohamed A. Tantawy Breakdown of academic impact, for papers by Fisayo A. Olotu
Rankless by CCL
2026